Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Human Papilloma Virus Testing Market Size, Share, & Trends Analysis Report by Application (Cervical Cancer Screening, Vaginal Cancer Screening), Product, Technology, End Use, Region, with Growth Forecasts, 2025-2030" report has been added to ResearchAndMarkets.com's offering.
The Human Papilloma Virus Testing Market was valued at USD 1.76 Billion in 2024, and is projected to reach USD 3.72 Billion by 2030, rising at a CAGR of 13.60%. Educational initiatives and public health campaigns encourage people to get tested regularly, leading to higher screening rates.
The adoption of at-home testing kits is further driving market expansion. These kits provide a convenient, private, and accessible method for individuals to test for HPV, empowering users to manage their health more proactively. The combination of heightened awareness and the availability of at-home testing is significantly boosting market demand.
Rising demand for preventive healthcare is projected to fuel the growth of the HPV testing industry, with more individuals seeking early detection to avoid HPV-related cancers. This shift toward proactive health measures encourages routine HPV screenings, especially for women over 30. Technological advancements in testing methods, including PCR-based and next-generation sequencing, are further enhancing the accuracy and efficiency of HPV tests. These innovations make testing more accessible, reliable, and cost-effective, thus driving market expansion by improving the overall patient experience and encouraging broader adoption of HPV testing solutions.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 110 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $1.76 Billion |
| Forecasted Market Value (USD) by 2030 | $3.72 Billion |
| Compound Annual Growth Rate | 13.6% |
| Regions Covered | Global |
Human Papilloma Virus (HPV) Testing Market Variables, Trends, & Scope
- Market Lineage Outlook
- Parent Market Outlook
- Related/Ancillary Market Outlook
- Market Dynamics
- Market Driver Analysis
- Market Restraint Analysis
- Human Papilloma Virus (HPV) Testing Market Analysis Tools
- Industry Analysis - Porter's Five Forces Analysis
- PESTLE Analysis
Global Human Papilloma Virus Testing Market Report: Segmentation
Application Outlook (Revenue, USD Million, 2018-2030)
- Cervical Cancer Screening
- Vaginal Cancer Screening
Product Outlook (Revenue, USD Million, 2018-2030)
- Instruments
- Consumables
- Services
Technology Outlook (Revenue, USD Million, 2018-2030)
- PCR
- Immunodiagnostics
- Others
End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Laboratories
- Others
Regional Outlook (Revenue, USD Million, 2018-2030)
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Companies Featured
- Abbott
- Biomedical Diagnostics
- bioMerieux
- CanAg Diagnostics (Beijing) Co., Ltd.
- Cemines
- Bio-Rad Laboratories, Inc.
- Epigenomics AG
- Fujirebio
- Guided Therapeutics, Inc.
- Oncolab
- Hologic, Inc.
- Qiagen
- Radiant Pharmaceuticals Limited
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers AG
For more information about this report visit https://www.researchandmarkets.com/r/i6p3c0
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
